Zevalin Plus Aggressive Chemotherapy Safe, Effective for Follicular Lymphoma, Phase 2 Trial Shows
News
Supplementing an aggressive chemotherapy regimen with Zevalin (ibritumomab tiuxetan) is safe and provides improved clinical response in patients with intermediate or high-risk follicular lymphoma, results from a Phase 2 clinical trial show. ... Read more